Active Surveillance vs Adjuvant Chemoradiotherapy for Locally Resected Intermediate-Risk T1 Rectal Cancer

NCT07669298 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

480

Enrollment

OTHER

Sponsor class

Conditions

Rectal Cancer

Interventions

OTHER: Active surveillance
RADIATION: Adjuvant chemoradiotherapy

Sponsor

Medical University of Gdansk

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]